Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model
| No. | 25 |
|---|---|
| Citation | Thromb Res 146,p69-75(2016) |
| Institute | Fujimori Kogyo |
| 1st Author | K Hosokawa |
| AR | ○ |
| PL | |
| HD | |
| Paper types | Basic science |
| Main purpose | Drug efficacy evaluation |
| Disease | |
| Antiplatelet drug | |
| Anticoagulant drug | |
| Other drug | PAI-1, t-PA, u-PA |
| Clinical specimens | |
| Animal | PAI-1 deficient mouse |
| Keyword |